会員登録
ログイン
【4528】小野薬品工業
製薬。がん免疫薬『オプジーボ』。
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025.03 | 2024/10/31 | Q2予 | 485,000 | ↑ | +7.8% | +7.8% | 82,000 | ↓ | -32.8% | -32.8% | 81,500 | ↓ | -33.7% | -33.7% | 58,000 | ↓ | -36.3% | -36.3% |
| 2025.03 | 2024/07/31 | Q1予 | 450,000 | → | 0.0% | 0.0% | 122,000 | → | 0.0% | 0.0% | 123,000 | → | 0.0% | 0.0% | 91,000 | → | 0.0% | 0.0% |
| 2025.03 | 2024/05/09 | 当初予 | 450,000 | - | - | - | 122,000 | - | - | - | 123,000 | - | - | - | 91,000 | - | - | - |
| 2024.03 | 2024/05/09 | 実 | 502,672 | ↑ | +0.5% | +5.8% | 159,935 | ↓ | -4.2% | +4.5% | 163,734 | ↓ | -3.1% | +6.3% | 127,977 | ↑ | +1.6% | +11.3% |
| 2024.03 | 2024/01/31 | Q3予 | 500,000 | → | 0.0% | +5.3% | 167,000 | → | 0.0% | +9.2% | 169,000 | → | 0.0% | +9.7% | 126,000 | → | 0.0% | +9.6% |
| 2024.03 | 2023/11/01 | Q2予 | 500,000 | ↑ | +5.3% | +5.3% | 167,000 | ↑ | +9.2% | +9.2% | 169,000 | ↑ | +9.7% | +9.7% | 126,000 | ↑ | +9.6% | +9.6% |
| 2024.03 | 2023/07/31 | Q1予 | 475,000 | → | 0.0% | 0.0% | 153,000 | → | 0.0% | 0.0% | 154,000 | → | 0.0% | 0.0% | 115,000 | → | 0.0% | 0.0% |
| 2024.03 | 2023/05/10 | 当初予 | 475,000 | - | - | - | 153,000 | - | - | - | 154,000 | - | - | - | 115,000 | - | - | - |
| 2023.03 | 2023/05/10 | 実 | 447,187 | ↑ | +1.6% | +5.2% | 141,963 | ↓ | -4.7% | -2.1% | 143,532 | ↓ | -4.3% | -1.7% | 112,723 | ↓ | -1.1% | +2.5% |
| 2023.03 | 2023/01/31 | Q3予 | 440,000 | → | 0.0% | +3.5% | 149,000 | → | 0.0% | +2.8% | 150,000 | → | 0.0% | +2.7% | 114,000 | → | 0.0% | +3.6% |
| 2023.03 | 2022/10/31 | Q2予 | 440,000 | ↑ | +3.5% | +3.5% | 149,000 | ↑ | +2.8% | +2.8% | 150,000 | ↑ | +2.7% | +2.7% | 114,000 | ↑ | +3.6% | +3.6% |
| 2023.03 | 2022/08/01 | Q1予 | 425,000 | → | 0.0% | 0.0% | 145,000 | → | 0.0% | 0.0% | 146,000 | → | 0.0% | 0.0% | 110,000 | → | 0.0% | 0.0% |
| 2023.03 | 2022/05/11 | 当初予 | 425,000 | - | - | - | 145,000 | - | - | - | 146,000 | - | - | - | 110,000 | - | - | - |
| 2022.03 | 2022/05/11 | 実 | 361,361 | ↑ | +0.4% | +3.2% | 103,195 | ↓ | -3.6% | -1.7% | 105,025 | ↓ | -3.6% | -1.8% | 80,519 | ↓ | -3.0% | -3.0% |
| 2022.03 | 2022/01/31 | Q3予 | 360,000 | ↑ | +4.3% | +2.9% | 107,000 | ↑ | +3.9% | +1.9% | 109,000 | ↑ | +3.8% | +1.9% | 83,000 | ↑ | +1.8% | 0.0% |
| 2022.03 | 2021/11/01 | Q2予 | 345,000 | → | 0.0% | -1.4% | 103,000 | → | 0.0% | -1.9% | 105,000 | → | 0.0% | -1.9% | 81,500 | → | 0.0% | -1.8% |
| 2022.03 | 2021/07/30 | Q1予 | 345,000 | ↓ | -1.4% | -1.4% | 103,000 | ↓ | -1.9% | -1.9% | 105,000 | ↓ | -1.9% | -1.9% | 81,500 | ↓ | -1.8% | -1.8% |
| 2022.03 | 2021/05/11 | 当初予 | 350,000 | - | - | - | 105,000 | - | - | - | 107,000 | - | - | - | 83,000 | - | - | - |
| 2021.03 | 2021/05/11 | 実 | 309,284 | ↑ | +0.1% | +2.1% | 98,330 | ↑ | +4.6% | +22.9% | 100,890 | ↑ | +5.6% | +23.0% | 75,425 | ↑ | +1.9% | +23.6% |
| 2021.03 | 2021/02/01 | Q3予 | 309,000 | ↑ | +1.3% | +2.0% | 94,000 | ↑ | +8.0% | +17.5% | 95,500 | ↑ | +7.9% | +16.5% | 74,000 | ↑ | +13.8% | +21.3% |
| 2021.03 | 2020/10/29 | Q2予 | 305,000 | ↑ | +0.7% | +0.7% | 87,000 | ↑ | +8.7% | +8.7% | 88,500 | ↑ | +7.9% | +7.9% | 65,000 | ↑ | +6.6% | +6.6% |
| 2021.03 | 2020/07/31 | Q1予 | 303,000 | → | 0.0% | 0.0% | 80,000 | → | 0.0% | 0.0% | 82,000 | → | 0.0% | 0.0% | 61,000 | → | 0.0% | 0.0% |
| 2021.03 | 2020/05/12 | 当初予 | 303,000 | - | - | - | 80,000 | - | - | - | 82,000 | - | - | - | 61,000 | - | - | - |
| 2020.03 | 2020/05/12 | 実 | 292,420 | ↑ | +0.8% | +0.8% | 77,491 | ↑ | +9.1% | +15.7% | 79,696 | ↑ | +9.2% | +13.9% | 59,704 | ↑ | +8.6% | +12.6% |
| 2020.03 | 2020/01/31 | Q3予 | 290,000 | → | 0.0% | 0.0% | 71,000 | ↑ | +6.0% | +6.0% | 73,000 | ↑ | +4.3% | +4.3% | 55,000 | ↑ | +3.8% | +3.8% |
| 2020.03 | 2019/10/31 | Q2予 | 290,000 | → | 0.0% | 0.0% | 67,000 | → | 0.0% | 0.0% | 70,000 | → | 0.0% | 0.0% | 53,000 | → | 0.0% | 0.0% |
| 2020.03 | 2019/08/01 | Q1予 | 290,000 | → | 0.0% | 0.0% | 67,000 | → | 0.0% | 0.0% | 70,000 | → | 0.0% | 0.0% | 53,000 | → | 0.0% | 0.0% |
| 2020.03 | 2019/05/09 | 当初予 | 290,000 | - | - | - | 67,000 | - | - | - | 70,000 | - | - | - | 53,000 | - | - | - |
| 2019.03 | 2019/05/09 | 実 | 288,634 | ↑ | +3.1% | +4.2% | 62,010 | ↓ | -2.3% | +0.8% | 65,141 | ↓ | -2.8% | +0.2% | 51,539 | ↓ | -0.9% | +2.1% |
| 2019.03 | 2019/02/01 | Q3予 | 280,000 | → | 0.0% | +1.1% | 63,500 | → | 0.0% | +3.3% | 67,000 | → | 0.0% | +3.1% | 52,000 | → | 0.0% | +3.0% |
| 2019.03 | 2018/11/01 | Q2予 | 280,000 | ↑ | +1.1% | +1.1% | 63,500 | ↑ | +3.3% | +3.3% | 67,000 | ↑ | +3.1% | +3.1% | 52,000 | ↑ | +3.0% | +3.0% |
| 2019.03 | 2018/08/01 | Q1予 | 277,000 | → | 0.0% | 0.0% | 61,500 | → | 0.0% | 0.0% | 65,000 | → | 0.0% | 0.0% | 50,500 | → | 0.0% | 0.0% |
| 2019.03 | 2018/05/10 | 当初予 | 277,000 | - | - | - | 61,500 | - | - | - | 65,000 | - | - | - | 50,500 | - | - | - |
| 2018.03 | 2018/05/10 | 実 | 261,836 | ↑ | +0.7% | +10.9% | 60,684 | ↑ | +11.3% | +66.3% | 63,922 | ↑ | +11.2% | +63.9% | 50,284 | ↑ | +16.9% | +73.4% |
| 2018.03 | 2018/02/02 | Q3予 | 260,000 | ↑ | +2.4% | +10.2% | 54,500 | ↑ | +9.0% | +49.3% | 57,500 | ↑ | +8.5% | +47.4% | 43,000 | ↑ | +8.9% | +48.3% |
| 2018.03 | 2017/11/06 | Q2予 | 254,000 | ↑ | +7.6% | +7.6% | 50,000 | ↑ | +37.0% | +37.0% | 53,000 | ↑ | +35.9% | +35.9% | 39,500 | ↑ | +36.2% | +36.2% |
| 2018.03 | 2017/08/02 | Q1予 | 236,000 | → | 0.0% | 0.0% | 36,500 | → | 0.0% | 0.0% | 39,000 | → | 0.0% | 0.0% | 29,000 | → | 0.0% | 0.0% |
| 2018.03 | 2017/05/11 | 当初予 | 236,000 | - | - | - | 36,500 | - | - | - | 39,000 | - | - | - | 29,000 | - | - | - |
| 2017.03 | 2017/05/11 | 実 | 244,797 | ↑ | +2.0% | -5.5% | 72,284 | ↑ | +5.5% | -0.3% | 74,540 | ↑ | +5.7% | -0.6% | 55,793 | ↑ | +6.7% | -0.0% |
| 2017.03 | 2017/02/02 | Q3予 | 240,000 | → | 0.0% | -7.3% | 68,500 | ↑ | +26.9% | -5.5% | 70,500 | ↑ | +25.9% | -6.0% | 52,300 | ↑ | +25.1% | -6.3% |
| 2017.03 | 2016/12/21 | 修正予 | 240,000 | ↓ | -7.3% | -7.3% | 54,000 | ↓ | -25.5% | -25.5% | 56,000 | ↓ | -25.3% | -25.3% | 41,800 | ↓ | -25.1% | -25.1% |
| 2017.03 | 2016/11/07 | Q2予 | 259,000 | → | 0.0% | 0.0% | 72,500 | → | 0.0% | 0.0% | 75,000 | → | 0.0% | 0.0% | 55,800 | → | 0.0% | 0.0% |
| 2017.03 | 2016/08/02 | 当初予 | 259,000 | - | - | - | 72,500 | - | - | - | 75,000 | - | - | - | 55,800 | - | - | - |
| 2016.03 | 2016/05/11 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 2016.03 | 2016/05/06 | 修正予 | 160,000 | ↑ | +2.6% | +18.4% | 30,000 | ↑ | +25.0% | +114.3% | 33,000 | ↑ | +24.5% | +100.0% | 25,000 | ↑ | +34.4% | +115.5% |
| 2016.03 | 2016/02/02 | Q3予 | 156,000 | ↑ | +8.0% | +15.5% | 24,000 | ↑ | +57.9% | +71.4% | 26,500 | ↑ | +48.9% | +60.6% | 18,600 | ↑ | +42.0% | +60.3% |
| 2016.03 | 2015/11/04 | Q2予 | 144,500 | ↑ | +7.0% | +7.0% | 15,200 | ↑ | +8.6% | +8.6% | 17,800 | ↑ | +7.9% | +7.9% | 13,100 | ↑ | +12.9% | +12.9% |
| 2016.03 | 2015/08/04 | Q1予 | 135,100 | → | 0.0% | 0.0% | 14,000 | - | - | - | 16,500 | → | 0.0% | 0.0% | 11,600 | → | 0.0% | 0.0% |
| 2016.03 | 2015/05/12 | 当初予 | 135,100 | - | - | - | - | - | - | - | 16,500 | - | - | - | 11,600 | - | - | - |
| 2015.03 | 2015/05/12 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 2015.03 | 2015/02/03 | Q3予 | 137,000 | ↑ | +5.9% | -1.4% | 15,100 | ↑ | +15.3% | -21.4% | 17,700 | ↑ | +12.7% | -18.8% | 12,000 | ↑ | +10.1% | -25.0% |
| 2015.03 | 2014/11/05 | Q2予 | 129,400 | ↓ | -6.9% | -6.9% | 13,100 | ↓ | -31.8% | -31.8% | 15,700 | ↓ | -28.0% | -28.0% | 10,900 | ↓ | -31.9% | -31.9% |
| 2015.03 | 2014/08/04 | Q1予 | 139,000 | → | 0.0% | 0.0% | 19,200 | → | 0.0% | 0.0% | 21,800 | → | 0.0% | 0.0% | 16,000 | → | 0.0% | 0.0% |
| 2015.03 | 2014/05/13 | 当初予 | 139,000 | - | - | - | 19,200 | - | - | - | 21,800 | - | - | - | 16,000 | - | - | - |
| 2014.03 | 2014/05/13 | 実 | 143,247 | ↓ | -3.4% | -3.4% | 26,423 | ↓ | -5.3% | -5.3% | 29,458 | ↑ | +1.6% | +1.6% | 20,350 | ↓ | -0.2% | -0.2% |
| 2014.03 | 2014/02/04 | 当初予 | 148,300 | - | - | - | 27,900 | - | - | - | 29,000 | - | - | - | 20,400 | - | - | - |
